In recent years, medications containing semaglutide such as Ozempic and Wegovy have gained popularity for their effectiveness in managing diabetes and aiding in weight loss. While these drugs have shown additional benefits beyond their primary uses, some negative side effects have also been identified. While gastrointestinal issues are commonly reported, a recent study by the University of British Columbia has linked GLP-1 agonists, including semaglutides, to a higher risk of hair loss.
Researchers examined data from a health claims database involving 16 million patients, focusing on 1,926 semaglutide users and 1,348 users of bupropion-naltrexone, another weight-loss medication. After adjusting for various factors, it was found that semaglutide users were 50% more likely to experience hair loss compared to the other group, with women being at a higher risk than men.
Dr. Mahyar Etminan, an epidemiologist involved in the study, explained that previous anecdotal reports and clinical trials had indicated a potential for hair loss with these drugs. Dr. Patrick Davis, a hair restoration expert, echoed these findings, emphasizing the role of factors such as diet, vitamins, stress, and genetics in hair health.
Davis noted that rapid weight loss induced by semaglutide could contribute to hair loss, especially in individuals who lost more than 20% of their body weight. However, he suggested that long-term hair loss may be less common as the body adjusts to weight changes over time.
Despite the limitations of the study, including the reliance on medical codes for identifying hair loss, the research points to a heightened risk of hair loss associated with semaglutide use, particularly among women. Davis also referenced another study showing an increased risk of hair loss among Wegovy users. Vigilance and monitoring of potential side effects are crucial for individuals using these medications.
“A very low rate of occurrence,” he stated. Study Reveals Hair Growth May Slow Down With This Popular Diet Plan, According to Research This preliminary study, published on the preprint server medRxiv, has not yet undergone peer review. “Further studies are needed to establish the connection between semaglutide and hair loss,” noted the researchers. Those experiencing hair loss while using semaglutide medications are advised to consult a dermatologist to determine if it is a side effect of these drugs, according to Etminan. “This is a relatively new adverse reaction and there is limited information about it,” he explained. “Questions regarding who is most susceptible and whether hair loss will reverse upon discontinuation of the drug can be addressed in future research.” Novo Nordisk, the manufacturer of Ozempic and Wegovy, confirmed to Fox News Digital that hair loss is a known risk associated with semaglutide and is listed as a potential side effect in the product information. Davis concurred, suggesting that patients speak openly with their healthcare provider about managing their well-being. “I believe patients should consider potential side effects before starting any medication,” he stated. “While the likelihood of hair loss is currently quite low, it is a possible consideration for patients.” Davis also recommended that his patients follow a nutritious diet rich in fiber, protein, and healthy foods to ensure proper nutrition while taking semaglutide medications.
Those experiencing hair loss while on semaglutide drugs should seek advice from a dermatologist to determine if it is a side effect of the medication, an expert suggested. “This not only could help with hair loss but more importantly, a healthy diet can help prevent the undesired loss of muscle mass often seen,” the expert explained. “A balanced diet, gradual weight loss approach, and exercise plan are crucial when using this medication.” For further health-related content, visit www.foxnews.com/health The study received internal research funding from the Department of Ophthalmology and Visual Sciences at the University of British Columbia, according to the journal article.
